EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan
Clinical trial NCT00071331 · COMPLETED
Trial details
- NCT number
- NCT00071331
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Primary completion
- 2006-07-01
- Enrollment
- 3600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.